|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gastroenteropancreatic neuroendocrine tumours显示文摘 | Irvin M Modlin Kjell Oberg Daniel C Chung Robert T Jensen Wouter W de Herder Rajesh V Thakker Martyn Caplin Gianfranco Delle Fave Greg A Kaltsas Eric P Krenning Steven F Moss Ola Nilsson Guido Rindi Ramon Salazar Philippe Ruszniewski Anders Sundin | 2008 | Lancet Oncology2008，，1： | 8 |
| 2 | Response to endoscopic therapy for biliary anastomotic strictures in deceased versus living donor liver transplantation显示文摘BACKGROUND:Endoscopic therapy has been successful in the management of biliary complications after both deceased donor liver transplantation(DDLT) and living donor liver transplantation(LDLT).LDLT is thought to be associated with higher rates of biliary complications,but there are few studies comparing the success of endoscopic management of anastomotic strictures between the two groups.This study aims to compare our experience in the endoscopic management of anastomotic strictures in DDLT versus LDLT.METHODS:This is a retrospective database review of all liver transplant patients undergoing endoscopic retrograde cholangiopancreatography(ERCP) after liver transplantation.The frequency of anastomotic stricture and the time to develop and to resolve anastomotic stricture were compared between DDLT and LDLT.The response of anastomotic stricture to endoscopic therapy was also analyzed.RESULTS:A total of 362 patients underwent liver transplantation between 2003 and 2011,with 125 requiring ERCP to manage biliary complications.Thirty-three(9.9%) cases of DDLT and 8(27.6%) of LDLT(P=0.01) were found to have anastomotic stricture.When comparing DDLT and LDLT,there was no difference in the mean time to the development of anastomotic strictures(98±17 vs 172±65 days,P=0.11),likelihood of response to ERCP [22(66.7%) vs 6(75.0%),P=0.69],mean time to the resolution of anastomotic strictures(268±77 vs 125±37 days,P=0.34),and the number of ERCPs required to achieve resolution(3.9±0.4 vs 4.7±0.9,P=0.38).CONCLUSIONS:Endoscopic therapy is effective in the majority of biliary complications relating to liver transplantation.Anastomotic strictures occur more frequently in LDLT compared with DDLT,with equivalent endoscopic treatment response and outcomes for both groups. | Calvin HY Chan Fergal Donnellan Michael F Byrne Alan Coss Mazhar Haque Holly Wiesenger Charles H Scudamore Urs P Steinbrecher Alan A Weiss Eric M Yoshida | 2013 | Hepatobiliary & Pancreatic Diseases International2013，12，5： | 7 |
| 3 | Colonoscopic yield of colorectal neoplasia in daily clinical practice显示文摘AIM:To assess the prevalence and location of ad-vanced neoplasia in patients undergoing colonoscopy,and to compare the yield per indication.METHODS:In a multicenter colonoscopy survey (n = 18 hospitals) in the Amsterdam area (Northern Holland),data of all colonoscopies performed during a three month period in 2005 were analyzed. The location and the histological features of all colonic neoplasia were recorded. The prevalence and the distribution ofadvanced colorectal neoplasia and differences in yield between indication clusters were evaluated. Advanced neoplasm was defi ned as adenoma > 10 mm in size,with > 25% villous features or with high-grade dyspla-sia or cancer.RESULTS:A total of 4623 eligible patients underwent a total colonoscopy. The prevalence of advanced neo-plasia was 13%,with 281 (6%) adenocarcinomas and 342 (7%) advanced adenomas. Sixty-seven percent and 33% of advanced neoplasia were located in the distal and proximal colon,respectively. Of all patients with right-sided advanced neoplasia (n = 228),51% had a normal distal colon,whereas 27% had a syn-chronous distal adenoma. Ten percent of all colono-scopies were performed in asymptomatic patients,7% of whom had advanced neoplasia. In the respective procedure indication clusters,the prevalence of right-sided advanced neoplasia ranged from 11%-57%. CONCLUSION:One out of every 7-8 colonoscopies yielded an advanced colorectal neoplasm. Colonoscopy is warranted for the evaluation of both symptomatic and asymptomatic patients. | Jochim S Terhaar sive Droste Mike E Craanen Rene WM van der Hulst Joep F Bartelsman Dick P Bezemer Kim R Cappendijk Gerrit A Meijer Linde M Morsink Pleun Snel Hans ARE Tuynman Roy LJ van Wanrooy Eric IC Wesdorp Chris JJ Mulder | 2009 | World Journal of Gastroenterology2009，15，9： | 6 |
| 4 | Mensenchymal progenitor cells in human umbilical cord blood 显示文摘 | Erices A Conget P Minguell JJ | 2000 | Br J Haematol2000，109，： | 2 |
| 5 | Mesenchymal stem cells显示文摘 | Minguell JJ Erices A Conger P | 2001 | Exp Biol Med2001，226，6： | 1 |
| 6 | Phosphorus diagenesis in lake sediments:investigation using fractionation techniques显示文摘 | Michael R P Martin T A Eric L V | 1995 | Mar Freshwater Res1995，46，： | 1 |
| 7 | A content analy- sis of the comprehensive income exposure draft comment letters 显示文摘 | Yen A C Eric Hirst D Hopkins P E | 2007 | Research in Accounting Regulation2007，19，： | 1 |
| 8 | Mesenchymal stem cells显示文摘 | Minguell JJ Erices A Conget P | 2001 | Exp Biol Med2001，226，6： | 1 |
| 9 | The Capture and Destruction of Escherichia coli from Simulated Urban Runoff Using Conventional Bioretention Media and Iron Oxide-coated Sand显示文摘 | Zhang Lan Seagren Eric A Davis Allen P Karns Jeffrey S | 2010 | Water Environment Research2010，，8： | 1 |
| 10 | Mesenchymal progenitor cells in human umbilical cord blood 显示文摘 | Erices A Conget P Minguell JJ | 2000 | Br J Haematol2000，109，： | 1 |
| 11 | Mesenchymal progenitor cells in human umbilical cord blood显示文摘 | Erices A Conget P Minguell JJ | 2000 | Br J Haematol2000，109，1： | 1 |
| 12 | Mesenchymal stem cells显示文摘 | Minguell JJ Erices A Conget P | 2001 | Exp Biol Med(Maywod)2001，226，6： | 1 |
| 13 | Mesenchymal stem cells 显示文摘 | Minguell J Erices A Conget P | 2001 | Ezp Biol Med2001，，： | 1 |
| 14 | Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody显示文摘 | Kenneth A Foon Xiao-Dong Yang Louis M Weiner Arie S Belldegrun Robert A Figlin Jeffrey Crawford Eric K Rowinsky Janice P Dutcher Nicholas J Vogelzang Jared Gollub John A Thompson Garry Schwartz Ronald M Bukowski Lorin K Roskos Gisela M Schwab | 2004 | International Journal of Radiation Oncology Biology Physics2004，，3： | 1 |
| 15 | Mesenchymal stem cells显示文摘 | Minguell JJ Erices A Conget P | | 0，，： | 1 |
| 16 | Mesenchymal Stem Cells显示文摘 | Minguell J Erices A Conget P | 2001 | Exp Biol Med2001，226，6： | 1 |
| 17 | Mesenchymal stem cells 显示文摘 | Minguell JJ Erices A Conget P | 2003 | Hum Ce112003，16，1： | 1 |
| 18 | Mesenchymal Stem Cells显示文摘 | Minguell J J Erices A Conget P | 2001 | Experi Biol Med2001，226，： | 1 |
| 19 | Mesenchymal stem cells 显示文摘 | Minguell J Erices A Conget P | 2001 | Exp Biol Med(naywood)2001，226，6： | 1 |
| 20 | Mesenchymal progenitors cell in human umbilical cord blood显示文摘 | Erices A Conget P Mingull JJ | 2000 | Br J Haematol2000，109，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员